Tenet Healthcare Corporation
$ 196.49
1.09%
21 Jul - close price
- Market Cap 16,925,060,000 USD
- Current Price $ 196.49
- High / Low $ 197.78 / 191.59
- Stock P/E 10.22
- Book Value 55.90
- EPS 19.22
- Next Earning Report 2026-07-24
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.30 %
- 52 Week High 247.21
- 52 Week Low 146.60
About
Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.
Analyst Target Price
$243.90
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-30 | 2026-02-11 | 2025-10-28 | 2025-07-22 | 2025-04-29 | 2025-02-12 | 2024-10-29 | 2024-07-24 | 2024-04-30 | 2024-02-08 | 2023-10-30 | 2023-07-31 |
| Reported EPS | 4.82 | 4.7 | 3.7 | 4.02 | 4.36 | 3.44 | 2.93 | 2.31 | 3.22 | 2.68 | 1.44 | 1.44 |
| Estimated EPS | 4.17 | 4.07 | 3.35 | 2.87 | 3.13 | 2.8324 | 2.37 | 1.91 | 1.44 | 1.62 | 1.2 | 1.25 |
| Surprise | 0.65 | 0.63 | 0.35 | 1.15 | 1.23 | 0.6076 | 0.56 | 0.4 | 1.78 | 1.06 | 0.24 | 0.19 |
| Surprise Percentage | 15.5875% | 15.4791% | 10.4478% | 40.0697% | 39.2971% | 21.4518% | 23.6287% | 20.9424% | 123.6111% | 65.4321% | 20% | 15.2% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-24 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 4.08 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.01 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: THC
2026-07-22 00:09:41
This article provides a bond profile for Tenet Healthcare Corporation's 6.875% bond maturing on November 15, 2031 (THC.GU). Key metrics such as issue date, maturity date, outstanding amount, face value, and coupon rate are detailed. The article also includes a brief business description of Tenet Healthcare Corporation.
2026-07-21 16:09:41
Tenet Healthcare Corporation (THC) is scheduled to report its second-quarter 2026 earnings on July 24, 2026. While the Zacks Consensus Estimate predicts a slight year-over-year increase in earnings and revenues, the company's Earnings ESP and a Zacks Rank #4 (Sell) suggest an uncertain outcome. Expected lower patient days and increased costs may impact the financial results, despite anticipated growth in its Ambulatory Care business.
2026-07-21 08:42:49
This article provides key metrics for the A3LHQH bond, issued by Tenet Healthcare Corporation. The bond has a coupon rate of 6.75% and matures on May 15, 2031. Tenet Healthcare, founded in 1969, operates through Hospital Operations and Ambulatory Care segments, including acute care hospitals and ambulatory centers.
2026-07-20 13:42:49
Tenet Healthcare Corporation (THC) is attracting investor interest with strong buy ratings and a potential 25% upside. Despite a recent slight dip, the company, valued at $16.79 billion, shows financial strength with a 30.29% return on equity and substantial free cash flow. Analysts are bullish, with an average target price of $243.90, making it an appealing prospect for growth-oriented investors in the healthcare sector.
2026-07-20 12:51:41
Tenet Healthcare Corporation (NYSE:THC) is set to release its Q2 2026 earnings on July 24, with analysts anticipating $4.26 EPS on revenues of $5.44 billion. This marks a significant 35.7% increase in EPS year-over-year, driven by strong operating leverage despite a more modest 3.2% revenue growth. Investors will be closely watching margin trends, same-facility admissions, and management's guidance for the second half of 2026 to assess the sustainability of this profitability.
2026-07-19 21:07:00
Tenet Healthcare (THC) appears undervalued, trading at a P/E ratio of 9.9x compared to an industry average of 26.0x and an estimated fair P/E of 19.0x. Despite a 172.1% total return over the past five years, valuation checks suggest the stock is still inexpensive relative to its fundamentals. The key question for investors is whether this discount reflects cautious sentiment or is justified by future profitability and capital needs.
